Cellectis S.A. (CLLS)

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $113.06 million. The enterprise value is $52.71 million.

Market Cap	113.06M
Enterprise Value	52.71M

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025, after market close.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.09 million shares outstanding. The number of shares has increased by 58.85% in one year.

Current Share Class	n/a
Shares Outstanding	72.09M
Shares Change (YoY)	+58.85%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	39.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.30
Forward PS	1.93
PB Ratio	0.86
P/TBV Ratio	0.87
P/FCF Ratio	5.54
P/OCF Ratio	4.92
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.58

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.67.

Current Ratio	1.73
Quick Ratio	1.00
Debt / Equity	0.67
Debt / EBITDA	n/a
Debt / FCF	4.33
Interest Coverage	-7.99

Financial Efficiency

Return on equity (ROE) is -34.08% and return on invested capital (ROIC) is -19.21%.

Return on Equity (ROE)	-34.08%
Return on Assets (ROA)	-10.37%
Return on Invested Capital (ROIC)	-19.21%
Return on Capital Employed (ROCE)	-27.41%
Revenue Per Employee	$221,698
Profits Per Employee	-$165,590
Employee Count	222
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.00% in the last 52 weeks. The beta is 3.38, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.38
52-Week Price Change	-38.00%
50-Day Moving Average	1.35
200-Day Moving Average	1.80
Relative Strength Index (RSI)	63.83
Average Volume (20 Days)	104,538

Short Selling Information

Short Interest	340,330
Short Previous Month	455,870
Short % of Shares Out	0.57%
Short % of Float	n/a
Short Ratio (days to cover)	0.59

Income Statement

In the last 12 months, Cellectis had revenue of $49.22 million and -$36.76 million in losses. Loss per share was -$0.41.

Revenue	49.22M
Gross Profit	49.22M
Operating Income	-59.56M
Pretax Income	-80.31M
Net Income	-36.76M
EBITDA	-48.25M
EBIT	-59.56M
Loss Per Share	-$0.41

Balance Sheet

The company has $143.25 million in cash and $88.27 million in debt, giving a net cash position of $54.98 million or $0.76 per share.

Cash & Cash Equivalents	143.25M
Total Debt	88.27M
Net Cash	54.98M
Net Cash Per Share	$0.76
Equity (Book Value)	131.03M
Book Value Per Share	1.82
Working Capital	120.80M

Cash Flow

In the last 12 months, operating cash flow was $22.99 million and capital expenditures -$2.58 million, giving a free cash flow of $20.41 million.

Operating Cash Flow	22.99M
Capital Expenditures	-2.58M
Free Cash Flow	20.41M
FCF Per Share	$0.28

Margins

Gross margin is 100.00%, with operating and profit margins of -121.00% and -74.69%.

Gross Margin	100.00%
Operating Margin	-121.00%
Pretax Margin	-74.69%
Profit Margin	-74.69%
EBITDA Margin	-98.04%
EBIT Margin	-121.00%
FCF Margin	41.46%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.85%
Shareholder Yield	n/a
Earnings Yield	-32.52%
FCF Yield	18.05%

Analyst Forecast

The average price target for Cellectis is $7.00, which is 351.61% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	351.61%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	27.62%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.73 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.73
Piotroski F-Score	5